search
Back to results

Inspiratory Muscle Training and Nasal High Flow in Difficult Weaning

Primary Purpose

High-risk for Reintubation Patients, Weaning Outcome

Status
Unknown status
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Inspiratory muscle Training and Nasal High Flow
Inspiratory muscle training and Venturi mask
Sponsored by
Evangelismos Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for High-risk for Reintubation Patients focused on measuring inspiratory muscle training, Nasal High Flow

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • >65 years,
  • BMI> 35kg/m2,
  • weak cough,
  • heart (i.e heart failure ) and lung comorbidities (i.e COPD),
  • hypercapnia during mechanical ventilation
  • > 72hours on mechanical ventilation
  • failed first spontaneous breathing trial

Exclusion Criteria:

  • Glasgow Coma scale (GCS)<13,
  • pre-existing neuromuscular disease or deformity of Spinal Cord,
  • terminal disease
  • hemodynamic instability with >0.1μg/kg/min noradrenaline
  • patients of immediately need of Non-invasive ventilation after extubation

Sites / Locations

  • Evangelismos HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Inspiratory Muscle Training and Nasal High Flow

Inspiratory Muscle Training and Venturi mask

Arm Description

Inspiratory Muscle Training will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Nasal High Flow will be applied immediately after extubation. IMT intervention will continue until patient's discharge from the ICU

IMT will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Venturi mask will be applied immediately after extubation. IMT intervention will continue until patient's discharge from the ICU

Outcomes

Primary Outcome Measures

Rate of weaning failure
Rate of weaning failure in high-risk for reintubation patients

Secondary Outcome Measures

Maximal Inspiratory Pressure
Maximal Inspiratory Pressure (MIP) will be assessed witn an unidirectional expiratory valve which permit exhalation while inspiration is blocked. One side of the valve will be attached to the patient's endotracheal tube and the other side to a manometer. Manometer could register pressures from 0 to 60 cmH20. Patients will be disconnected from the ventilator and attached to the valve for a period of more than 30 sec. The most negative value will be recorded
Maximal Expiratory Pressure
Maximal Expiratory Pressure (MEP) will be assessed witn an unidirectional inspiratory valve which permit inspiration while expiration is blocked. One side of the valve will be attached to the patient's endotracheal tube and the other side to a manometer. Manometer could register pressures from 0 to 60 cmH20. Patients will be disconnected from the ventilator and attached to the valve for a period of more than 30 sec. The highest value will be recorded
Endurance of respiratory muscles
Endurance of respiratory muscles will be calculated comparing the preloading and postloading values of the MIP
Muscle strenght
Muscle strength will be assessed by the sum of Medical Research Council (MRC) scale for muscle strength in 6 different muscle groups ( shoulder abductors, forearm flexors, wrist flexors, hip flexors, knee extensors and plantar dorsiflexors) for both body sides. Each muscle group scores from 0 (no contraction) up to 5 (movement against gravity) and the total score range from 0 (worse outcome) up to 60 (best outcome)
Functional ability
Functional ability will be assessed by Functional Independence Measure (FIM) which includes 18 questions (13 motor tasks and 5 cognitive tasks). Each item is scored on a 7 point ordinal scale, ranging from a score of 1 (total inability-dependence) to a score of 7 (total independence). The higher the score, the more independent the patient is in performing the task associated with that item.The total score for the FIM motor subscale (the sum of the individual motor subscale items) will be a value between 13 and 91. The total score for the FIM cognition subscale (the sum of the individual cognition subscale items) will be a value between 5 and 35. The total score for the FIM instrument (the sum of the motor and cognition subscale scores) will be a value between 18 (total dependency) and 126 total indepedency
Short Form 36 Health Survey (SF-36) questionnaire
Quality of life (QoL) will be assessed by Short Form 36 Health Survey (SF-36) which includes 36 items to measure 8 QoL domains. More specifically, from SF-36 only the domains parts of Physical Functioning (PF) which includes 10 questions with possible scores from 1 to 3, the Role Physical (RF) which includes 4 yes or no questions, the Social Functioning (SF) which includes 2 questions with possible scores form 1 to 5 and the Mental Health domain (MH) which includes 9 questions with possible scores form 1 to 9 will be used. Regarding the scoring of the questions 1 is the worst outcome. Each domain is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Euro-Qol 5 Dimensions 5 Level of severity scale (Euro-Qol 5D-5L scale)
Euro-Qol 5D-5L questionnaire includes 5 domains and an optic analogue scale from 0 (worse) up to 100 (best). Each domain (mobility, self care, usual activities, pain / discomfort, anxiety / depression) scores from 1(best score) up to 5 (worse score). The total score of all domains ranges from 5 (best score) up to 25 (worse score).The total perceived quality of life will be graded by the patient.

Full Information

First Posted
April 4, 2019
Last Updated
February 11, 2020
Sponsor
Evangelismos Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03908658
Brief Title
Inspiratory Muscle Training and Nasal High Flow in Difficult Weaning
Official Title
The Effectiveness of Inspiratory Muscle Training and Nasal High Flow Oxygen in Difficult Weaning of ICU Patients
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Unknown status
Study Start Date
March 20, 2019 (Actual)
Primary Completion Date
January 1, 2021 (Anticipated)
Study Completion Date
March 20, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Evangelismos Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the present study is to investigate the effectiveness of inspiratory muscle training and nasal high flow oxygen in patients with difficult weaning and high-risk for re-intubation. The hypothesis of the study is that starting inspiratory muscle training once patients are awake and co-operative along with the application of nasal high flow oxygen immediately after extubation will have a beneficial effect in preventive re-intubation in these high-risk patients.
Detailed Description
20-30% of intubated patients are difficult to be weaned off the mechanical ventilation and have a prolonged ICU stay. It is well established that prolonged ICU stay is associated with reduced muscle strength, functional ability and quality of life. Inspiratory muscle training (IMT) via a threshold device has been proposed as an effective exercise for minimizing the detrimental effect of mechanical ventilation in critical ill patients with prolonged weaning. Additionally, Nasal High Flow (NHF) oxygen has been proved to support efficiently either high or low-risk patients after extubation and thus preventing re-intubation. A randomized intervention study was designed to assess the efficacy of combining IMT and NHF as therapeutic strategies for difficult weaning. Once patients with prognostic factors of difficult weaning are awake and co-operative they will be randomized to one of the two following study groups: 1) IMT and NHF group, 2) IMT and Venturi mask group. IMT will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Each allocated oxygen delivery device will be applied immediately after extubation. IMT intervention will continue until patients' discharge from the ICU.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
High-risk for Reintubation Patients, Weaning Outcome
Keywords
inspiratory muscle training, Nasal High Flow

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
146 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Inspiratory Muscle Training and Nasal High Flow
Arm Type
Active Comparator
Arm Description
Inspiratory Muscle Training will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Nasal High Flow will be applied immediately after extubation. IMT intervention will continue until patient's discharge from the ICU
Arm Title
Inspiratory Muscle Training and Venturi mask
Arm Type
Active Comparator
Arm Description
IMT will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Venturi mask will be applied immediately after extubation. IMT intervention will continue until patient's discharge from the ICU
Intervention Type
Other
Intervention Name(s)
Inspiratory muscle Training and Nasal High Flow
Intervention Description
Inspiratory muscle Training will be used to increase respiratory muscle strength. Initial settings will depend on patient's maximal inspiratory pressure. Nasal High Flow will support respiratory muscles and thus reduce the work of breathing. By this mechanism the endurance of the respiratory muscles will increase in parallel with the strenght
Intervention Type
Device
Intervention Name(s)
Inspiratory muscle training and Venturi mask
Intervention Description
Inspiratory muscle Training will be used to increase respiratory muscle strength. Initial settings will depend on patient's maximal inspiratory pressure. Venturi mask is usually applied after extubation in every day clinical practice for oxygen supplementation
Primary Outcome Measure Information:
Title
Rate of weaning failure
Description
Rate of weaning failure in high-risk for reintubation patients
Time Frame
48 hours after extubation
Secondary Outcome Measure Information:
Title
Maximal Inspiratory Pressure
Description
Maximal Inspiratory Pressure (MIP) will be assessed witn an unidirectional expiratory valve which permit exhalation while inspiration is blocked. One side of the valve will be attached to the patient's endotracheal tube and the other side to a manometer. Manometer could register pressures from 0 to 60 cmH20. Patients will be disconnected from the ventilator and attached to the valve for a period of more than 30 sec. The most negative value will be recorded
Time Frame
Within 2 hours after patient randomization, within 24 hours after extubation, within 24 hours after ICU discharge
Title
Maximal Expiratory Pressure
Description
Maximal Expiratory Pressure (MEP) will be assessed witn an unidirectional inspiratory valve which permit inspiration while expiration is blocked. One side of the valve will be attached to the patient's endotracheal tube and the other side to a manometer. Manometer could register pressures from 0 to 60 cmH20. Patients will be disconnected from the ventilator and attached to the valve for a period of more than 30 sec. The highest value will be recorded
Time Frame
Within 2 hours after patient randomization, within 24 hours after extubation, within 24 hours after ICU discharge
Title
Endurance of respiratory muscles
Description
Endurance of respiratory muscles will be calculated comparing the preloading and postloading values of the MIP
Time Frame
Within 2 hours after patient randomization, within 24 hours after extubation , within 24 hours after ICU discharge
Title
Muscle strenght
Description
Muscle strength will be assessed by the sum of Medical Research Council (MRC) scale for muscle strength in 6 different muscle groups ( shoulder abductors, forearm flexors, wrist flexors, hip flexors, knee extensors and plantar dorsiflexors) for both body sides. Each muscle group scores from 0 (no contraction) up to 5 (movement against gravity) and the total score range from 0 (worse outcome) up to 60 (best outcome)
Time Frame
Within 2 hours after patient randomization, within 24 hours after ICU discharge, within 24 hours before hospital discharge
Title
Functional ability
Description
Functional ability will be assessed by Functional Independence Measure (FIM) which includes 18 questions (13 motor tasks and 5 cognitive tasks). Each item is scored on a 7 point ordinal scale, ranging from a score of 1 (total inability-dependence) to a score of 7 (total independence). The higher the score, the more independent the patient is in performing the task associated with that item.The total score for the FIM motor subscale (the sum of the individual motor subscale items) will be a value between 13 and 91. The total score for the FIM cognition subscale (the sum of the individual cognition subscale items) will be a value between 5 and 35. The total score for the FIM instrument (the sum of the motor and cognition subscale scores) will be a value between 18 (total dependency) and 126 total indepedency
Time Frame
Within 24 hours after ICU discharge, within 24 hours before hospital discharge
Title
Short Form 36 Health Survey (SF-36) questionnaire
Description
Quality of life (QoL) will be assessed by Short Form 36 Health Survey (SF-36) which includes 36 items to measure 8 QoL domains. More specifically, from SF-36 only the domains parts of Physical Functioning (PF) which includes 10 questions with possible scores from 1 to 3, the Role Physical (RF) which includes 4 yes or no questions, the Social Functioning (SF) which includes 2 questions with possible scores form 1 to 5 and the Mental Health domain (MH) which includes 9 questions with possible scores form 1 to 9 will be used. Regarding the scoring of the questions 1 is the worst outcome. Each domain is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Time Frame
Within 24 hours before hospital discharge
Title
Euro-Qol 5 Dimensions 5 Level of severity scale (Euro-Qol 5D-5L scale)
Description
Euro-Qol 5D-5L questionnaire includes 5 domains and an optic analogue scale from 0 (worse) up to 100 (best). Each domain (mobility, self care, usual activities, pain / discomfort, anxiety / depression) scores from 1(best score) up to 5 (worse score). The total score of all domains ranges from 5 (best score) up to 25 (worse score).The total perceived quality of life will be graded by the patient.
Time Frame
Within 24 hours before hospital discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: >65 years, BMI> 35kg/m2, weak cough, heart (i.e heart failure ) and lung comorbidities (i.e COPD), hypercapnia during mechanical ventilation > 72hours on mechanical ventilation failed first spontaneous breathing trial Exclusion Criteria: Glasgow Coma scale (GCS)<13, pre-existing neuromuscular disease or deformity of Spinal Cord, terminal disease hemodynamic instability with >0.1μg/kg/min noradrenaline patients of immediately need of Non-invasive ventilation after extubation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Christakou
Phone
+306977370284
Email
achristakou@phed.uoa.gr
First Name & Middle Initial & Last Name or Official Title & Degree
Irini Patsaki
Phone
+306942064363
Email
ipatsaki@yahoo.gr
Facility Information:
Facility Name
Evangelismos Hospital
City
Athens
ZIP/Postal Code
10676
Country
Greece
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Christakou
Phone
+306977370284
Email
achristakou@phed.uoa.gr
First Name & Middle Initial & Last Name & Degree
Irini Patsaki
Phone
+306942064363
Email
ipatsaki@yahoo.gr
First Name & Middle Initial & Last Name & Degree
Emmanouil Papadopoulos
First Name & Middle Initial & Last Name & Degree
Alexandros Kouvarakos
First Name & Middle Initial & Last Name & Degree
Martha Katartzi
First Name & Middle Initial & Last Name & Degree
Eleni Ischaki

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Participants' data will be available will be available following publication
IPD Sharing Time Frame
following publication

Learn more about this trial

Inspiratory Muscle Training and Nasal High Flow in Difficult Weaning

We'll reach out to this number within 24 hrs